Acanya Side Effects
Please note - some side effects for Acanya may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Side Effects of Acanya - for the Consumer
Acanya Gel
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Acanya Gel:
Seek medical attention right away if any of these SEVERE side effects occur when using Acanya Gel:Mild burning, dryness, itching, peeling, redness, or stinging of the skin.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody stools; severe burning, dryness, itching, peeling, redness, stinging, or swelling of the skin; severe or persistent watery diarrhea; stomach cramps or pain.
Acanya Side Effects - for the Professional
Acanya
The following selected adverse reactions occurred in less than 0.2% of patients treated with Acanya Gel: application site pain (0.1%); application site exfoliation (0.1%); and application site irritation (0.1%). (6.1)
To report SUSPECTED ADVERSE REACTIONS, contact ARCUTIS Pharmaceuticals at 1-877-272-8808 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Side Effects by Body System
Dermatologic
Dermatologic side effects have included dry skin (12%), pruritus (2%), peeling (2%), erythema (1%), and sunburn (1%) and reactions at the application site (3%).
Application site reactions including burning, stinging, and pruritus are frequently reported following topical application of the combination of 5% benzoyl peroxide and 1% clindamycin.
Gastrointestinal
Pseudomembranous colitis may be revealed upon endoscopic examination; stool cultures for Clostridium difficile, and stool assays for Clostridium difficile toxin may be helpful diagnostically.
Gastrointestinal side effects have been reported with the use of topical clindamycin. Diarrhea, bloody diarrhea, and colitis, including pseudomembranous colitis, have occurred. Colitis usually manifests as severe persistent diarrhea, severe abdominal cramps, and passage of blood and mucous. Some cases of colitis have been fatal. Due to the possible serious nature of pseudomembranous colitis, patients should be advised to discontinue clindamycin therapy and consult a physician if diarrhea occurs.
TopDisclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
A to Z Drug List
Drugs by Condition
Drug Side Effects
Natural Products
Community Forums
Interactions Checker
MedNotes
Support Groups
Drug Image Search
Phonetic Search
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Clinical Trial Results
Medical Encyclopedia
News Feeds
Drugs by Classification
Patient Care Notes
Drug Imprint Codes
Medical Dictionary
Subscribe to our popular newsletter containing a regular roundup of medication news, alerts and new drug approvals.
